Big effect

A probiotic blend doubled the response rate for IBS symptoms at 28 days — but the benefit came from two strains together, not BB-12 alone, and the overall gut microbiome barely budged.

This is one of the first rigorous trials on this specific probiotic pairing, so the results are promising but far from settled — the real-world impact depends on whether the combination, not just BB-12, drives the effect, and other measures like overall microbiome composition didn't change.

In an 84-day trial, adults with non-constipated IBS who took a blend of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis BB-12 were more than twice as likely to report symptom improvement by day 28 compared to placebo (19.3% vs 8.9%). Pain, bloating, and quality-of-life scores also improved. However, the study tested a two-strain product, not BB-12 alone, and found no major shift in the overall gut bacteria community, meaning the mechanism remains unclear and the evidence is still early.

Where this fits in the evidence

This is among the first studies we've indexed on Bifidobacterium animalis subsp. lactis BB-12 for Improved Irritable Bowel Syndrome Symptoms — treat it as an early signal until more research accumulates.

The study

Probiotic Blend of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis ssp. Lactis BB-12 in Non-constipated Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial.

Randomized Controlled Trial (RCT)
2025-11-18
Journal of gastroenterology and hepatology

More on Bifidobacterium animalis subsp. lactis BB-12 More on Improved Irritable Bowel Syndrome Symptoms

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.